Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Determination of voriconazole in saliva in patients with invasive fungal infection
2012-001396-37Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Apr 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of voriconazole in mycoses, sponsored by UZ Leuven. Primary endpoint: Pharmacokinetics of voriconazole in saliva. Started Apr 2021; status: completed.
02
Drugs
voriconazole
03
Conditions
mycoses
Beyond the preview
Go deeper on 2012-001396-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001396-37.